Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.
Watch our Sandoz TV video series to discover more about the world of Sandoz and generics.
Novartis is pleased to announce that GBCHealth, a coalition of more than 230 private sector companies working to improve global health, has awarded the company's Arogya Parivar program the Business Action on Health Award for Application of Core Competence. Arogya Parivar is a sustainable business model that makes affordable, high-quality medicines accessible to underserved millions in India. The program also expands access to health education and consultations in remote villages.
Each year, Sandoz associates around the world give back to their communities by participating in Novartis Community Partnership Day
You are on the website of Sandoz International. Please select from the above dropdown to visit a local website.
Drug regulatory regulations and medical practices can be different from one country to another. As a result the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.
Take a virtual journey into the historical roots of our company.Explore our history >
Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population. Learn more about our commitment to patients, doctors and healthcare professionals, as well as the communities in which we live and work. More about Sandoz
As part of the Novartis group, we believe that superior quality is key to our long-term success. Our state-of-the-art technologies, decades of experience, and rigorous across-the-board quality standards all contribute to an offer we are justly proud of: quality at a price that everyone can afford. More about our Quality Standards
Sandoz was the first company to develop and market follow-on versions of highly complex biopharmaceuticals. Today, we are the undisputed global leader in this segment and have an industry-leading pipeline that will make essential biopharmaceuticals more affordable for all. Discover Sandoz biosimilars
Going beyond standard generics, we use innovation and expertise to develop even the most complex medicines that add value to patient healthcare – from biosimilars and complex injectables to respiratory and specialty generics. Global access to cost-effective treatment: this is how we are shaping the future of patient healthcare. Read about Sandoz Oncology Injectables